Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genentech, Inc.
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
National Cancer Institute (NCI)
Providence Health & Services
The Methodist Hospital Research Institute
OncoC4, Inc.
Genmab
USWM, LLC (dba US WorldMeds)
KaliVir Immunotherapeutics
Pfizer
Eastern Cooperative Oncology Group
Pfizer
Aulos Bioscience, Inc.
Ipsen
Sotio Biotech Inc.
Pfizer
Pfizer
Pfizer
M.D. Anderson Cancer Center
Bayer
Mayo Clinic
Dragonfly Therapeutics
Stanford University
AstraZeneca
Seagen Inc.
Merck Sharp & Dohme LLC
Mayo Clinic
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
Neonc Technologies, Inc.
ViroMissile, Inc.
Erasca, Inc.
Kaiser Permanente
Pfizer
Radiopharm Theranostics, Ltd
Arvinas Inc.
Tizona Therapeutics, Inc
Boehringer Ingelheim
M.D. Anderson Cancer Center
Daiichi Sankyo
OHSU Knight Cancer Institute
MacroGenics
DualityBio Inc.
MacroGenics